Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

समान संसाधन

• Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
  द्वारा: Horby, P, और अन्य
  प्रकाशित: (2021)
• Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
  द्वारा: Mafham, M, और अन्य
  प्रकाशित: (2021)
• Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
  द्वारा: Landray, M, और अन्य
  प्रकाशित: (2022)
• Methylprednisolone, intravenous immunoglobulin, tocilizimab or anakinra for children with Paediatric Inflammatory Multisystem Syndrome temporally associated with SARS CoV-2 (PIMS-TS, MIS-C) – report from a randomised, controlled, open-label, platform trial
  द्वारा: Haynes, R, और अन्य
  प्रकाशित: (2023)
• Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
  द्वारा: Horby, P, और अन्य
  प्रकाशित: (2024)